Vanda Pharmaceuticals Inc.

MetLife Investment Management, LLC VNDA

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/12/2026

Shares

24,410

Value ($000)

215

Weight

0.0%

2018 Q3 - 2025 Q4 (30 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/12/2026	215	0.0%	24,410	12/31/2025
2025 Q3	11/13/2025	161	0.0%	32,309	9/30/2025
2025 Q2	8/13/2025	155	0.0%	32,860	6/30/2025
2025 Q1	5/14/2025	151	0.0%	32,816	3/31/2025
2024 Q4	2/13/2025	132	0.0%	27,606	12/31/2024
2024 Q3	11/13/2024	155	0.0%	33,088	9/30/2024
2024 Q2	8/13/2024	187	0.0%	33,088	6/30/2024
2024 Q1	5/14/2024	122	0.0%	29,764	3/31/2024
2023 Q4	4/22/2024	129	0.0%	30,601	12/31/2023
2023 Q3	5/9/2024	132	0.0%	30,601	9/30/2023
2023 Q2	4/29/2024	202	0.0%	30,601	6/30/2023
2023 Q1	5/9/2024	208	0.0%	30,601	3/31/2023
2022 Q4	5/10/2024	226	0.0%	30,601	12/31/2022
2022 Q3	5/10/2024	302	0.0%	30,601	9/30/2022
2022 Q2	5/10/2024	334	0.0%	30,601	6/30/2022
2022 Q1	5/10/2024	346	0.0%	30,601	3/31/2022
2021 Q4	5/17/2024	308	0.0%	19,612	12/31/2021
2021 Q3	5/17/2024	280	0.0%	16,331	9/30/2021
2021 Q2	5/17/2024	460	0.0%	21,384	6/30/2021
2021 Q1	5/17/2024	321	0.0%	21,384	3/31/2021
2020 Q4	5/24/2024	320	0.0%	24,336	12/31/2020
2020 Q3	5/24/2024	235	0.0%	24,336	9/30/2020
2020 Q2	5/24/2024	278	0.0%	24,336	6/30/2020
2020 Q1	7/12/2023	252	0.0%	24,336	3/31/2020
2019 Q4	7/12/2023	399	0.0%	24,336	12/31/2019
2019 Q3	7/12/2023	323	0.0%	24,336	9/30/2019
2019 Q2	7/12/2023	343	0.0%	24,336	6/30/2019
2019 Q1	7/13/2023	448	0.0%	24,336	3/31/2019
2018 Q4	7/13/2023	636	0.0%	24,336	12/31/2018
2018 Q3	7/13/2023	559	0.0%	24,336	9/30/2018